Modafinil is widely used in the startup world. I have been part of the entrepreneurial community for 8 years and have watched the culture around it evolve. Here is an honest take.
Why entrepreneurs use it:
- Long hours without proportional energy
- Multiple simultaneous demands requiring sustained attention
- The pressure to out-execute competitors
- A culture of biohacking and self-optimisation
Where it genuinely helps:
- Long sprints on specific technical or analytical problems
- Maintaining quality on repetitive but important tasks
- Recovering functional days after necessary late nights
Where the “entrepreneur drug” narrative gets it wrong:
- Modafinil cannot generate insight. The vision and strategy that matters most in startups comes from the non-modafinil cognitive processes.
- It encourages ignoring the fundamentals: sleep, exercise, and diet produce far more cognitive benefit than any drug.
- The culture can normalise unsustainable work patterns rather than solving them.
My honest verdict: Useful tool, dangerous mythology.
The “useful tool, dangerous mythology” framing is sharp and fair. Silicon Valley modafinil culture has a lot to answer for in terms of unrealistic expectations and enabling unsustainable work cultures.
Survivorship bias matters here too. We hear about the founders who used modafinil and succeeded. We do not hear as much from those who used it, crashed, and failed. The causality is hard to establish.
The distinction between finite sprint use and ongoing normalisation is the key variable. Most of the horror stories about modafinil in startup culture are about the second category.
As someone 3 years into running a company: the times I have had the clearest product insight have almost always been on rest days. Modafinil days produce excellent execution but the ideas that changed the trajectory of the company came from the unstructured mind.
The “normalising unsustainable work patterns” critique is important. If modafinil is enabling 80-hour weeks sustainably, you have patched a problem rather than fixed it.
On the other hand, startups have genuine sprint periods where unsustainable short-term work is not just encouraged but necessary. Modafinil as a finite tool for a defined crunch period is different from ongoing lifestyle normalisation.
The insight generation point is crucial for founders specifically. Product vision, market intuition, and creative problem-solving — the most valuable CEO skills — are not helped by modafinil. If anything, the focused tunnel vision could hurt.
For what it is worth: the best operators I know in the startup world are the ones who guard their sleep and health most carefully. The heavy drug users often burn bright for a while and then crash.